GlassScriptPhysician profile
Ashley Anne Joseph
NPI 1548618606
$6,710.70
in general payments reported to CMS, 2019-2025
22 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.59 · 2020: $3,832 · 2021: $1,166 · 2022: $79.78 · 2023: $707 · 2024: $568 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569 · Education: $32.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.15 |
| Education | $32.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,761.00 | 2019-2024 | Proclaim |
| Boston Scientific Corporation | $842.87 | 2020-2023 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $750.45 | 2021-2025 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $462.24 | 2022-2025 | Belbuca, Xtampza |
| Nevro Corp. | $272.17 | 2020-2021 | |
| Spinal Simplicity, LLC | $103.68 | 2024-2025 | Ha Minuteman G3-R |
| Valinor Pharma, LLC | $98.76 | 2023-2024 | Movantik |
| Nalu Medical, INC. | $94.02 | 2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $41.72 | 2024-2025 | |
| Merz Pharmaceuticals, LLC | $32.28 | 2023 | Xeomin |
| Vertos Medical, INC. | $31.60 | 2020 | |
| Curonix LLC | $30.51 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $29.72 | 2024 | Qutenza |
| Stryker Corporation | $25.50 | 2020 | |
| Spr Therapeutics, INC | $20.31 | 2023 | Sprint Pns System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $19.22 | 2024 | Generator |
| Biotronik Nro, INC. | $16.91 | 2025 | Prospera |
| Globus Medical, INC. | $16.71 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $16.51 | 2023 | Ztlido |
| Fidia Pharma USA INC. | $16.47 | 2023 | Hymovis, Triluron |
| Saluda Medical Americas, INC. | $15.94 | 2025 | Evoke |
| Arbor Pharmaceuticals, INC. | $12.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.